James Mulay

James Mulay has an estimated net worth of $3.68 Million. This is based on reported shares across multiple companies, which include Fulgent Genetics, Inc., and CG Oncology, Inc..

2025 was James Mulay's most active year for acquiring shares with 6 total transactions. James Mulay's most active month to acquire stocks was the month of August. 2025 was James Mulay's most active year for disposing of shares, totalling 13 transactions. James Mulay's most active month to dispose stocks was the month of August. 2026 saw James Mulay paying a total of $724,868.35 for 28,709 shares, this is the most they've acquired in one year. In 2026 James Mulay cashed out on 57,418 shares for a total of $1,848,468.73, their largest year based on trade value.